Citations (43)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (2)
Mao Yang, Ningning Xi, Meng Gao & Yanwei Yu. (2022) Sitagliptin mitigates hypoxia/reoxygenation (H/R)-induced injury in cardiomyocytes by mediating sirtuin 3 (SIRT3) and autophagy. Bioengineered 13:5, pages 13162-13173.
Read now
Read now
Tavga Ahmed Aziz. (2021) Cardioprotective Effect of Quercetin and Sitagliptin in Doxorubicin-Induced Cardiac Toxicity in Rats. Cancer Management and Research 13, pages 2349-2357.
Read now
Read now
Articles from other publishers (41)
Daniela Maria Tanase, Evelina Maria Gosav, Madalina Ioana Anton, Mariana Floria, Petronela Nicoleta Seritean Isac, Loredana Liliana Hurjui, Claudia Cristina Tarniceriu, Claudia Florida Costea, Manuela Ciocoiu & Ciprian Rezus. (2022) Oxidative Stress and NRF2/KEAP1/ARE Pathway in Diabetic Kidney Disease (DKD): New Perspectives. Biomolecules 12:9, pages 1227.
Crossref
Crossref
Hugo Ramos, Patricia Bogdanov, Jordi Huerta, Anna Deàs-Just, Cristina Hernández & Rafael Simó. (2022) Antioxidant Effects of DPP-4 Inhibitors in Early Stages of Experimental Diabetic Retinopathy. Antioxidants 11:7, pages 1418.
Crossref
Crossref
Hayder M. Al-kuraishy, Ali I. Al-Gareeb, Naeem Qusty, Athanasios Alexiou & Gaber El-Saber Batiha. (2022) Impact of Sitagliptin on Non-diabetic Covid-19 Patients. Current Molecular Pharmacology 15:4, pages 683-692.
Crossref
Crossref
Prabhakar Busa, Yaswanth Kuthati, Niancih Huang & Chih-Shung Wong. (2022) New Advances on Pathophysiology of Diabetes Neuropathy and Pain Management: Potential Role of Melatonin and DPP-4 Inhibitors. Frontiers in Pharmacology 13.
Crossref
Crossref
Shuai Huang, Gen Chen, Jia Sun, Yunjie Chen, Nan Wang, Yetong Dong, Enzhao Shen, Zhicheng Hu, Wenjie Gong, Litai Jin & Weitao Cong. (2021) Histone deacetylase 3 inhibition alleviates type 2 diabetes mellitus-induced endothelial dysfunction via Nrf2. Cell Communication and Signaling 19:1.
Crossref
Crossref
Xijun Zhang, Jianjun Yuan, Nanqian Zhou, Kaikai Shen, Yisa Wang, Ke Wang & Haohui Zhu. (2021) Omarigliptin Prevents TNF-α-Induced Cellular Senescence in Rat Aorta Vascular Smooth Muscle Cells. Chemical Research in Toxicology 34:9, pages 2024-2031.
Crossref
Crossref
Yaswanth Kuthati, Vaikar Navakanth Rao, Prabhakar Busa & Chih-Shung Wong. (2021) Teneligliptin Exerts Antinociceptive Effects in Rat Model of Partial Sciatic Nerve Transection Induced Neuropathic Pain. Antioxidants 10:9, pages 1438.
Crossref
Crossref
Xin Wang, Jing Ke, Ying-jun Zhu, Bin Cao, Rui-li Yin, Yan Wang, Ling-ling Wei, Li-jie Zhang, Long-yan Yang & Dong Zhao. (2021) Dipeptidyl peptidase-4 (DPP4) inhibitor sitagliptin alleviates liver inflammation of diabetic mice by acting as a ROS scavenger and inhibiting the NFκB pathway. Cell Death Discovery 7:1.
Crossref
Crossref
Huijiao Lin, Xinyun Zhang, Dan Wang, Jiawei Liu, Liwei Yuan, Jiale Liu, Chunmei Wang, Jinghui Sun, Jianguang Chen, He Li & Shu Jing. (2021) Anwulignan Ameliorates the Intestinal Ischemia/Reperfusion. Journal of Pharmacology and Experimental Therapeutics 378:3, pages 222-234.
Crossref
Crossref
Habib Yaribeygi, Stephen L. Atkin, Fabrizio Montecucco, Tannaz Jamialahmadi & Amirhossein Sahebkar. (2021) Renoprotective Effects of Incretin-Based Therapy in Diabetes Mellitus. BioMed Research International 2021, pages 1-7.
Crossref
Crossref
Jie Wang, Mengjie Xiao, Jie Wang, Shudong Wang, Jingjing Zhang, Yuanfang Guo, Yufeng Tang & Junlian Gu. (2021) NRF2-Related Epigenetic Modifications in Cardiac and Vascular Complications of Diabetes Mellitus. Frontiers in Endocrinology 12.
Crossref
Crossref
Yu Cao, Zhao Yang, Ying Chen, Shuai Jiang, Zhen Wu, Baoping Ding, Yang Yang, Zhenxiao Jin & Haifeng Tang. (2021) An Overview of the Posttranslational Modifications and Related Molecular Mechanisms in Diabetic Nephropathy. Frontiers in Cell and Developmental Biology 9.
Crossref
Crossref
Habib Yaribeygi, Mina Maleki, Thozhukat Sathyapalan, Tannaz Jamialahmadi & Amirhossein Sahebkar. (2021) Antioxidative Potentials of Incretin-Based Medications: A Review of Molecular Mechanisms. Oxidative Medicine and Cellular Longevity 2021, pages 1-9.
Crossref
Crossref
Xiaoyun He, Gaoyan Kuang, Yi Zuo, Shuangxi Li, Suxian Zhou & Chunlin Ou. (2021) The Role of Non-coding RNAs in Diabetic Nephropathy-Related Oxidative Stress. Frontiers in Medicine 8.
Crossref
Crossref
Daiji Kawanami, Yuichi Takashi, Hiroyuki Takahashi, Ryoko Motonaga & Makito Tanabe. (2021) Renoprotective Effects of DPP-4 Inhibitors. Antioxidants 10:2, pages 246.
Crossref
Crossref
Ju-Chi Liu, Po-Yuan Chen, Wen-Rui Hao, Yi-Chung Liu, Ping-Chiang Lyu & Hong-Jye Hong. (2020) Cafestol Inhibits High-Glucose-Induced Cardiac Fibrosis in Cardiac Fibroblasts and Type 1-Like Diabetic Rats. Evidence-Based Complementary and Alternative Medicine 2020, pages 1-11.
Crossref
Crossref
Avinash Kumar, Rashmi Pathak, Henry A. Palfrey, Kirsten P. Stone, Thomas W. Gettys & Subramanyam N. Murthy. (2020) High levels of dietary methionine improves sitagliptin-induced hepatotoxicity by attenuating oxidative stress in hypercholesterolemic rats. Nutrition & Metabolism 17:1.
Crossref
Crossref
Jiarong Lv, Yu Wu, Yifeng Mai & Shizhong Bu. (2020) Noncoding RNAs in Diabetic Nephropathy: Pathogenesis, Biomarkers, and Therapy. Journal of Diabetes Research 2020, pages 1-10.
Crossref
Crossref
Nao Shigematsu, Takehiro Kawashiri, Daisuke Kobayashi, Shiori Shimizu, Keisuke Mine, Shiori Hiromoto, Mayako Uchida, Nobuaki Egashira & Takao Shimazoe. (2020) Neuroprotective effect of alogliptin on oxaliplatin-induced peripheral neuropathy in vivo and in vitro. Scientific Reports 10:1.
Crossref
Crossref
Kosuke OkabeShouji MatsushimaSoichiro IkedaMasataka IkedaAkihito IshikitaTomonori TadokoroNobuyuki EnzanTaishi YamamotoMasashi SadaHiroko DeguchiKeisuke ShinoharaTomomi IdeHiroyuki Tsutsui. (2020) DPP (Dipeptidyl Peptidase)-4 Inhibitor Attenuates Ang II (Angiotensin II)–Induced Cardiac Hypertrophy via GLP (Glucagon-Like Peptide)-1–Dependent Suppression of Nox (Nicotinamide Adenine Dinucleotide Phosphate Oxidase) 4-HDAC (Histone Deacetylase) 4 Pathway. Hypertension 75:4, pages 991-1001.
Crossref
Crossref
Akira Mima, Toshinori Yasuzawa, Tomomi Nakamura & Shigeru Ueshima. (2020) Linagliptin affects IRS1/Akt signaling and prevents high glucose-induced apoptosis in podocytes. Scientific Reports 10:1.
Crossref
Crossref
Shaohua Xian, Jing Li & Zhengfu Zhang. (2020) miR‑26b inhibits isoproterenol‑induced cardiac fibrosis via the Keap1/Nrf2 signaling pathway. Experimental and Therapeutic Medicine.
Crossref
Crossref
Wafaa Ahmed Hewedy. (2020) Effects of treatment with sitagliptin on hepatotoxicity induced by acetaminophen in mice. Brazilian Journal of Pharmaceutical Sciences 56.
Crossref
Crossref
Seham A. Abdel-Gaber, Ayman Geddawy & Rabab A. Moussa. (2019) The hepatoprotective effect of sitagliptin against hepatic ischemia reperfusion-induced injury in rats involves Nrf-2/HO-1 pathway. Pharmacological Reports 71:6, pages 1044-1049.
Crossref
Crossref
Ahmad Ghasemi, Seyed Isaac Hashemy, Mohsen Azimi-Nezhad, Alireza Dehghani, Jafar Saeidi & Mahnaz Mohtashami. (2019) The cross-talk between adipokines and miRNAs in health and obesity-mediated diseases. Clinica Chimica Acta 499, pages 41-53.
Crossref
Crossref
Małgorzata Trocha, Małgorzata Krzystek-Korpacka, Anna Merwid-Ląd, Beata Nowak, Małgorzata Pieśniewska, Piotr Dzięgiel, Agnieszka Gomułkiewicz, Przemysław Kowalski, Dorota Diakowska, Adam Szeląg & Tomasz Sozański. (2019) Sitagliptin-Dependent Differences in the Intensity of Oxidative Stress in Rat Livers Subjected to Ischemia and Reperfusion. Oxidative Medicine and Cellular Longevity 2019, pages 1-10.
Crossref
Crossref
Wenbin Shi, Daisong Zhang, Lei Wang, Nagaraja Sreeharsha & Yushan Ning. (2019) Curcumin synergistically potentiates the protective effect of sitagliptin against chronic deltamethrin nephrotoxicity in rats: Impact on pro‐inflammatory cytokines and Nrf2/Ho‐1 pathway. Journal of Biochemical and Molecular Toxicology 33:10.
Crossref
Crossref
Burgos-Morón, Abad-Jiménez, Marañón, Iannantuoni, Escribano-López, López-Domènech, Salom, Jover, Mora, Roldan, Solá, Rocha & Víctor. (2019) Relationship Between Oxidative Stress, ER Stress, and Inflammation in Type 2 Diabetes: The Battle Continues. Journal of Clinical Medicine 8:9, pages 1385.
Crossref
Crossref
Linicene Rosa do Nascimento & Caroline Pereira Domingueti. (2019) MicroRNAs: new biomarkers and promising therapeutic targets for diabetic kidney disease. Brazilian Journal of Nephrology 41:3, pages 412-422.
Crossref
Crossref
Marko Anderluh, Gordana Kocic, Katarina Tomovic, Hristina Kocic & Andrija Smelcerovic. (2019) DPP-4 inhibition: А novel therapeutic approach to the treatment of pulmonary hypertension?. Pharmacology & Therapeutics 201, pages 1-7.
Crossref
Crossref
Yuping Li, Qiangyuan Tian, Zhe Li, Minyan Dang, Yukiat Lin & Xunyao Hou. (2019) Activation of Nrf2 signaling by sitagliptin and quercetin combination against β‐amyloid induced Alzheimer's disease in rats. Drug Development Research 80:6, pages 837-845.
Crossref
Crossref
Mahsa Darbandi, Sara Darbandi, Ashok Agarwal, Saradha Baskaran, Pallav Sengupta, Sulagna Dutta, Pooneh Mokarram, Kioomars Saliminejad & Mohammad Reza Sadeghi. (2019)
Oxidative stress-induced alterations in seminal plasma antioxidants: Is there any association with
keap1
gene methylation in human spermatozoa?
. Andrologia 51:1, pages e13159.
Crossref
Crossref
Sudhiranjan Gupta. 2019. Modulation of Oxidative Stress in Heart Disease. Modulation of Oxidative Stress in Heart Disease
63
80
.
Hua Su, Cheng Wan, Anni Song, Yang Qiu, Wei Xiong & Chun Zhang. 2019. Renal Fibrosis: Mechanisms and Therapies. Renal Fibrosis: Mechanisms and Therapies
585
604
.
Isabel Nguyen, Arianne van Koppen & Jaap A. Joles. 2019. Diabetic Nephropathy. Diabetic Nephropathy
375
413
.
Alieh Gholaminejad, Hossein Abdul Tehrani & Mohammad Gholami Fesharaki. (2018) Identification of candidate microRNA biomarkers in diabetic nephropathy: a meta-analysis of profiling studies. Journal of Nephrology 31:6, pages 813-831.
Crossref
Crossref
Dan-Dan Qiu, Jing Liu, Jing-Song Shi, Yu An, Yong-Chun Ge, Min-Lin Zhou & Song Jiang. (2018) Renoprotection Provided by Dipeptidyl Peptidase-4 Inhibitors in Combination with Angiotensin Receptor Blockers in Patients with Type 2 Diabetic Nephropathy. Chinese Medical Journal 131:22, pages 2658-2665.
Crossref
Crossref
Habib Yaribeygi, Niki Katsiki, Behzad Behnam, Helia Iranpanah & Amirhossein Sahebkar. (2018) MicroRNAs and type 2 diabetes mellitus: Molecular mechanisms and the effect of antidiabetic drug treatment. Metabolism 87, pages 48-55.
Crossref
Crossref
Jian Zhang, Zheng Xu, Junlian Gu, Saizhi Jiang, Quan Liu, Yang Zheng, Jonathan H. Freedman, Jian Sun & Lu Cai. (2018) HDAC3 inhibition in diabetic mice may activate Nrf2 preventing diabetes-induced liver damage and FGF21 synthesis and secretion leading to aortic protection. American Journal of Physiology-Endocrinology and Metabolism 315:2, pages E150-E162.
Crossref
Crossref
Netanya Y. Spencer, Zhihong Yang, Jensyn Cone Sullivan, Thomas Klein & Robert C. Stanton. (2018) Linagliptin unmasks specific antioxidant pathways protective against albuminuria and kidney hypertrophy in a mouse model of diabetes. PLOS ONE 13:7, pages e0200249.
Crossref
Crossref
Yoon Oh & Hee-Sook Jun. (2017) Effects of Glucagon-Like Peptide-1 on Oxidative Stress and Nrf2 Signaling. International Journal of Molecular Sciences 19:1, pages 26.
Crossref
Crossref